Skip to main content
. 2021 Apr 27;10(5):1033. doi: 10.3390/cells10051033

Table 1.

Summary of the MRGPRX2/MRGPRB2 agonists (peptides, non-peptides and natural compounds).

SN Agonist Major Findings References
Peptide Agonist
1 CST-14
  • MRGPRX2-dependent MC activation, degranulation and cytokine release

  • Increased Ca2+ mobilization

  • Involvement of store-operated Ca2+ entry via stim1

[72,75,104]
2 Substance P
  • Presence of MRGPRs in primary sensory neurons and on nerve endings of dorsal root ganglion

  • MRGPRX2-dependent activation of human skin-derived cultured MCs

  • MRGPRX2-dependent itch response

[46,67,70]
3 Somatostatin
  • MRGPRX2-dependent MC degranulation

[45,73]
4 PACAP
  • MRGPRX2-dependent MC degranulation

[45]
5 VIP
  • MRGPRX2-dependent MC degranulation

[45]
6 LL-37
  • MRGPRX2-dependent LL-37 induces MC degranulation, chemokine generation, and chemotaxis

  • Increased Ca2+ mobilization

[50,103]
7 β-defensins
  • Identification of MRGPRX2 in human β-defensin-induced MC degranulation

  • Increased vascular permeability in rats

[103]
8 Indolicidin
  • Increased Ca2+ influx in MRGPRX2-expressing cells

  • Dose-dependent degranulation of human MCs

[45]
9 PAMP 20
  • Identified as an endogenous ligand for MRGPRX2

  • Similar binding site as of Cortistatin

[75,105]
10 Mastoparan
  • Concentration-dependent MRGPRX2 activation

  • Concentration-dependent MC degranulation and inflammatory mediators release activity

[72,91]
11 Human eosinophil granules
  • MRGPRX2-dependent activation of human MCs

  • Identified major basic protein-1 (MBP-1) and major basic protein-2 (MBP-2), eosinophil peroxidase (EPO) and eosinophil cationic protein (ECP) as MRGPRX2 agonists

[45,46,106]
12 Proteases
  • Identified cysteine endopeptidase cathepsin S and mucunain allergic response via MRGPRX2

  • MRGPRX2-dependent chronic inflammation and itch response

[107,108]
13 AG-30/5C
  • Identified AG-30/5C as biased MRGPRX2 agonist

  • Induction of chemotaxis and cytokine production via MRGPRX2-mediated MC activation

[95]
14 AMP-IBP5
  • Identified AMP-IBP5 as MRGPRX2 agonist

  • Role in wound healing through MCs–MRGPRX2

  • AMP-IBP5 shown Ca2+ flux followed by MC degranulation and release PGDs, and cytokines/chemokines.

[48]
15 GnRHR agonist and antagonist
  • Sermorelin and octreotide as MRGPRX2 agonist

  • Increased Ca2+ mobilization in MRGPRX2-transfected cells

[72]
Non-peptide agonist
1 Compound 48/80
  • MRGPRX2-dependent MC activation of different population of MCs

  • Increased Ca2+ mobilization, and cytokine release

[45,72,109]
2 Fluoroquinolone antibiotics (ciprofloxacin)
  • MRGPRX2-dependent hypersensitivity reaction by topical fluoroquinolone ophthalmic preparation

  • Concentration-dependent MC degranulation, and MRGPRX2-dependent Ca2+ release by ciprofloxacin

  • Dose dependent MC degranulation, Ca2+ release and increased vascular permeability

[72,110,111]
3 NMBAs (rocuronium, mivacurium, and atracurium)
  • Rocuronium-induced non-IgE-mediated allergic reaction clinically

  • Concentration-dependent MCs–MRGPRX2/MRGPRB2 by rocuronium

  • MC Ca2+ mobilization and degranulation concentration-dependent activation of MRGPRX2, MC degranulation, histamine and inflammatory cytokine release by mivacurium

  • Increased paw extravasation and decreased body temperature by mivacurium

[72,85,112]
4 Opioids (morphine, pethidine chloride, dextrorphan, levorphanol)
  • MRGPRX2-mediated MC activation and intrathecal mass formation.

  • Concentration-dependent MRGPRX2 activation and MC activity of morphine

  • Dextro-enantiomers and N-methyl scaffolds of opioids and endogenous opioid ligands activates MCs via MRGPRX2

  • Increased Ca2+ mobilization and MC degranulation activity

  • Concentration-dependent human MC degranulation and inflammatory cytokine release by pethidine hydrocholoride

[87,113,114]
5 Antidepressant drugs (clomipramine paroxetine and desipramine
  • Concentration-dependent activation of MRGPRX2/MRGPRB2 and MC activation

  • Induced scratch behavior in mice

  • Clomipramine showed wheal-and-flare reaction on intradermal injection and activated human skin MCs

[115]
6 Others (Icatibant, iopamidol, vancomycin, baicalein, and sinomemnin)
  • MRGPRX2/MRGPRB2 activation

  • MC degranulation and Ca2+ mobilization

  • Induced tissue extravasation and cytokine release

[72,92,95,116]